RPCI ONCOLOGY PC (EIN 461355351) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2012

Legal Domicile

Principal Officer

SAIKRISHNA YENDAMURI MD

Phone

7168452300

Tax Period

2024-04-01 to 2025-03-31

RPCI ONCOLOGY PC, founded in 2012, is a major nonprofit in the Health Care sector that reported $102.1M in total revenue in fiscal year 2024. Revenue grew 10% year-over-year, indicating healthy expansion.

Mission

THE PURPOSE OF THE ORGANIZATION IS EXCLUSIVELY CHARITABLE, SCIENTIFIC AND EDUCATIONAL, PARTICULARLY TO ENGAGE IN THE PRACTICE OF MEDICINE AND RELATED SERVICES IN FURTHERANCE OF THE PUBLIC AND CHARITABLE PURPOSES OF ROSWELL PARK CANCER INSTITUTE AND HEALTH RESEARCH INCORPORATED BY PROMOTING ACCESS TO QUALITY HEALTHCARE SERVICES THROUGH THE RECRUITMENT AND EMPLOYMENT OF PHYSICIANS AS NECESSARY TO MEET THE NEEDS OF THIER LOCAL COMMUNITIES.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $16,035,790

Program Service Revenue $76,511,900

Investment Income $0

Other Revenue $9,516,592

TOTAL REVENUE $102,064,282

Expense Breakdown

Grants Paid $0

Salaries & Benefits $36,334,398

Fundraising Expenses $0

Program Expenses $90,390,446

Other Expenses $67,131,904

TOTAL EXPENSES $103,466,302

Year-over-Year Comparison

	2024	2023	Change
Revenue	$102,064,282	$92,946,657	+0.1%
Expenses	$103,466,302	$89,022,612	+0.2%
Net Income	$-1,402,020	$3,924,045	-1.4%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

N/A

Employees

313

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$1,462,646

Total Directors

$2,966,908

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
SAIFUDDIN SONIWALA MD	BOARD MEMBER / PHYSICIAN	40.00	Director	$692,608	$34,676	$727,284
MARIOLA POSS MD	BOARD MEMBER / PHYSICIAN	40.00	Director	$470,192	$25,419	$495,611
BHUVANA RAMKUMAR MD	BOARD MEMBER / PHYSICIAN	40.00	Director	$700,129	$32,478	$732,607
SAIKRISHNA YENDAMURI MD	BOARD MEMBER/CEO	40.00	Officer Director	$0	$50,443	$1,011,406
DAVID TEAR	VP OF COMMUNITY PRACTICES	40.00	Officer	$0	$25,900	$451,240
ADAM KOTOWSKI MD	PHYSICIAN	40.00	Highest	$908,596	$24,896	$933,492
ELIZABETH CONROY MD	PHYSICIAN	40.00	Highest	$706,810	$18,965	$725,775
PAUL BOGNER MD	PHYSICIAN	40.00	Highest	$1,064,587	$30,506	$1,095,093
HASAN RIZVI MD	PHYSICIAN	40.00	Highest	$959,349	$6,847	$966,196
DANIEL BAX MD	PHYSICIAN	40.00	Highest	$640,615	$33,336	$673,951
PHILIP LESZAK	FORMER COO	40.00		$141,726	$7,613	$149,339

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$102,064,282	$103,466,302	$32,599,022	$-1,402,020
2024	$92,946,657	$89,022,612	$28,552,779	$3,924,045
2023	$77,412,531	$74,784,491	$24,129,628	$2,628,040
2022	$66,318,134	$66,254,550	$19,088,362	$63,584
2021	$55,982,882	$55,873,631	$16,914,565	$109,251
2020	$57,706,060	$55,506,061	$18,836,393	$2,199,999
2019	$50,047,504	$52,383,675	$15,448,371	$-2,336,171
2018	$44,016,074	$46,060,617	$14,309,415	$-2,044,543
2018	$46,767,673	$46,060,617	$17,061,014	$707,056

RPCI ONCOLOGY PC